Get the Stockscreener App
0.735
3.29%
-0.025
Pre-market:
.74
0.005
+0.68%
Tilray Brands Inc stock is traded at $0.735, with a volume of 40.34M.
It is down -3.29% in the last 24 hours and down -30.00% over the past month.
Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.
See More
Previous Close:
$0.76
Open:
$0.76
24h Volume:
40.34M
Relative Volume:
0.98
Market Cap:
$686.47M
Revenue:
$829.22M
Net Income/Loss:
$-248.96M
P/E Ratio:
-2.45
EPS:
-0.3
Net Cash Flow:
$-92.10M
1W Performance:
-22.75%
1M Performance:
-30.00%
6M Performance:
-57.02%
1Y Performance:
-57.51%
1-Day Range:
$0.7157
$0.7611
1-Week Range:
$0.7157
$0.9101
52-Week Range:
$0.7157
$2.97
Tilray Brands Inc Stock (TLRY) Company Profile
Name
Tilray Brands Inc
Sector
Phone
519.322.8800
Address
655 MADISON AVENUE, NEW YORK
Compare TLRY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TLRY
Tilray Brands Inc
|
0.735 | 686.47M | 829.22M | -248.96M | -92.10M | -0.30 |
|
ZTS
Zoetis Inc
|
167.24 | 74.89B | 9.26B | 2.49B | 2.30B | 5.47 |
|
HLN
Haleon Plc Adr
|
10.18 | 46.03B | 14.35B | 1.85B | 0 | 0.4023 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.41 | 45.69B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.46 | 18.86B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ITCI
Intra Cellular Therapies Inc
|
128.20 | 13.63B | 612.78M | -86.37M | -62.91M | -0.87 |
Tilray Brands Inc Stock (TLRY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-05-24 | Reiterated | Alliance Global Partners | Neutral |
| Nov-02-22 | Initiated | Bernstein | Mkt Perform |
| Jul-29-22 | Downgrade | The Benchmark Company | Hold → Sell |
| Mar-04-22 | Upgrade | Canaccord Genuity | Hold → Buy |
| Nov-18-21 | Initiated | Barclays | Underweight |
| Nov-01-21 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-11-21 | Downgrade | CIBC | Sector Outperform → Neutral |
| Jun-03-21 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| May-11-21 | Resumed | Cowen | Outperform |
| May-07-21 | Resumed | Jefferies | Buy |
| May-06-21 | Initiated | Canaccord Genuity | Buy |
| Apr-28-21 | Resumed | BofA Securities | Buy |
| Feb-18-21 | Downgrade | Piper Sandler | Overweight → Neutral |
| Feb-18-21 | Downgrade | The Benchmark Company | Buy → Hold |
| Nov-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Nov-11-20 | Downgrade | Stifel | Hold → Sell |
| Oct-01-20 | Reiterated | MKM Partners | Neutral |
| Sep-21-20 | Upgrade | Jefferies | Underperform → Hold |
| May-12-20 | Reiterated | The Benchmark Company | Buy |
| Apr-16-20 | Downgrade | Jefferies | Hold → Underperform |
| Apr-09-20 | Downgrade | Consumer Edge Research | Overweight → Equal Weight |
| Feb-24-20 | Downgrade | Cowen | Outperform → Market Perform |
| Jan-13-20 | Initiated | BofA/Merrill | Neutral |
| Nov-13-19 | Reiterated | The Benchmark Company | Buy |
| Nov-05-19 | Initiated | Cantor Fitzgerald | Neutral |
| Oct-22-19 | Reiterated | Piper Jaffray | Overweight |
| Sep-20-19 | Initiated | MKM Partners | Neutral |
| Aug-14-19 | Reiterated | The Benchmark Company | Buy |
| Jul-17-19 | Initiated | Ladenburg Thalmann | Neutral |
| Jun-28-19 | Initiated | Consumer Edge Research | Overweight |
| Jun-06-19 | Initiated | Stifel | Hold |
| Jun-05-19 | Initiated | Oppenheimer | Perform |
| May-15-19 | Upgrade | BMO Capital Markets | Underperform → Market Perform |
| May-13-19 | Initiated | Alliance Global Partners | Neutral |
View All
Tilray Brands Inc Stock (TLRY) Latest News
Tilray Brands Inc. stock falls Friday, underperforms market - MarketWatch
Tilray Brands Inc. stock falls Thursday, underperforms market - MarketWatch
Tilray stock touches 52-week low at $0.78 amid market challenges - Investing.com
Tilray stock touches 52-week low at $0.78 amid market challenges By Investing.com - Investing.com South Africa
Tilray Brands, Inc. (TLRY) Stock Dips While Market Gains: Key Facts - MSN
Tilray Refinances Loan to Strengthen Financial Stability - TipRanks
Tilray Brands Announces 420 Concert with Multi-Platinum Artist Don Toliver - Markets Insider
Tilray's 420 Celebration Pairs Don Toliver Concert With Exclusive New High-Potency Vape Release - StockTitan
TLRY stock news today: Is Tilray stock expected to go up? - Markets.com
Tilray Brands Inc. stock falls Tuesday, underperforms market - MarketWatch
Montauk Brewing Takes Flight - East Hampton Star
Tilray Brands Inc. stock falls Monday, underperforms market - MarketWatch
Tilray stock price crashes below $1: buy the dip or sell the rip? - MSN
Tilray Brands Inc. stock rises Friday, outperforms market - MarketWatch
Tilray (TLRY): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Tilray Brands, Inc. (TLRY) Declines More Than Market: Some Information for Investors - MSN
Good Supply Introduces New Monsters Resin Vapes: Full Spectrum Highs - GlobeNewswire
Delaware court frees former Tilray partners from $13M Marley licensing fee - Green Market Report
12 Best Get Rich Fast Stocks To Buy Now - Insider Monkey
Is Tilray Brands, Inc. (TLRY) the Best Get Rich Fast Stock to Buy Now? - Insider Monkey
Good Supply Introduces New Monsters Resin Vapes: Full Spectrum Highs -February 20, 2025 at 08:03 am EST - Marketscreener.com
Tilray Brands Inc. stock falls Wednesday, underperforms market - MarketWatch
Tilray Brands, Inc. (TLRY) Outpaces Stock Market Gains: What You Should Know - MSN
Looking Into Tilray Brands's Recent Short Interest - Benzinga
Tilray stock touches 52-week low at $0.9 amid market challenges - Investing.com India
Decibel Expands General Admission Brand's International Footprint - Cannabis Business Times
HYTN, A1 Cannabis Partner to Scale Production of Cannabis Products - Cannabis Business Times
Tilray (NASDAQ:TLRY) Trading Down 0.1%What's Next? - MarketBeat
Top Cannabis Stocks To Watch TodayFebruary 17th - MarketBeat
Tilray (NASDAQ:TLRY) Trading Down 1.1%Should You Sell? - MarketBeat
Tilray (NASDAQ:TLRY) Shares Down 3.7%Here's Why - MarketBeat
Tilray: Improved Balance Sheet And Reasonable Valuation (Rating Upgrade) - Seeking Alpha
Tilray (NASDAQ:TLRY) Stock Price Down 0.5%What's Next? - MarketBeat
2 Beaten-Down Stocks to Avoid - MSN
Tilray (NASDAQ:TLRY) Stock Price Down 0.1%Here's What Happened - MarketBeat
Best Cannabis Stocks To Follow TodayFebruary 15th - MarketBeat
Tilray (NASDAQ:TLRY) Stock Price Down 3.7%What's Next? - MarketBeat
Top Cannabis Stocks To ConsiderFebruary 13th - MarketBeat
Tilray (NASDAQ:TLRY) Trading Down 4%What's Next? - MarketBeat
Best Cannabis Stocks To ConsiderFebruary 14th - MarketBeat
Tilray Brands, Inc. (TLRY) Ascends While Market Falls: Some Facts to Note - MSN
Cannabis Stocks To ResearchFebruary 12th - MarketBeat
StockTalk | Cannabis Report: Vapes, ketamine, and celebrity endorsements | 2025-02-14 | Investing News - Stockhouse Publishing
Tilray (NASDAQ:TLRY) Trading Down 5.2%Time to Sell? - MarketBeat
Tilray Brands Inc. stock rises Wednesday, outperforms market - MarketWatch
Tilray Ceases Large-Scale Production at Revolver; Taproom Remains Open - Brewbound.com
Tilray Medical Expands Medical Cannabis Portfolio in Germany -February 11, 2025 at 07:00 am EST - Marketscreener.com
Beyond Germany: Other international markets for cannabis opportunities - Green Market Report
Tilray élargit son portefeuille de produits à base de cannabis thérapeutique en Allemagne - GlobeNewswire Inc.
Tilray Brands Inc Stock (TLRY) Financials Data
Revenue
Net Income
Cash Flow
EPS
Tilray Brands Inc Stock (TLRY) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Persofsky Renah | Director |
Nov 08 '24 |
Option Exercise |
1.50 |
11,958 |
17,937 |
75,348 |
| SIMON IRWIN D | President and CEO |
Jul 31 '24 |
Option Exercise |
2.03 |
706,214 |
1,433,614 |
3,637,021 |
| Merton Carl A | Chief Financial Officer |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
703,412 |
| Gendel Mitchell | Global General Counsel |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
468,218 |
| FALTISCHEK DENISE M | Chief Strategy Officer |
Jul 31 '24 |
Option Exercise |
2.03 |
93,926 |
190,670 |
583,643 |
| SIMON IRWIN D | President and CEO |
Jul 26 '24 |
Option Exercise |
1.83 |
98,194 |
179,695 |
2,985,109 |
| Merton Carl A | Chief Financial Officer |
Jul 26 '24 |
Option Exercise |
1.83 |
12,166 |
22,264 |
615,102 |
| Looney Thomas P. | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
230,038 |
| Hopkinson David G. | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
211,185 |
| Herhalt Johann Michael | Director |
Jul 26 '24 |
Option Exercise |
1.83 |
129,534 |
237,047 |
180,514 |
2.29%
3.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):